| Media Production of Prison Communities |
coordinator |
ERC-2024-ADG |
€2,500,000 |
| GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA |
participant |
HORIZON-JU-GH-EDCTP3-2022-01 |
€999,499 |
| Green valorization of CO2 and Nitrogen compounds for making fertilizers |
participant |
HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 |
€993,275 |
| Protein-based next generation electronics |
coordinator |
HORIZON-EIC-2021-PATHFINDEROPEN-01 |
€892,750 |
| Endoscopic brush cytology and single cell clinal dynamics of early easop |
coordinator |
HORIZON-MISS-2023-CANCER-01 |
€698,052 |
| Prodrugs oF antiparasitic RedOx-active compoundS |
participant |
HORIZON-EIC-2025-PATHFINDEROPEN |
€570,134 |
| High mobilitY Printed nEtwoRks of 2D Semiconductors for advanced electrO |
participant |
HORIZON-EIC-2023-PATHFINDEROPEN-01 |
€518,625 |
| Affordable Cryo-EM through Computational Enhancement of Structural Studi |
participant |
HORIZON-EIC-2025-TRANSITIONOPEN |
€503,770 |
| Severe neonatal infection adaptive platform trials in Africa |
participant |
HORIZON-JU-GH-EDCTP3-2022-01 |
€438,336 |
| Revolutionizing the Waste of Waste: A new Bioeconomy-based business for |
participant |
HORIZON-EIC-2025-PATHFINDEROPEN |
€403,125 |
| Impact of MPXV infection on pregnancy outcome and newborn health |
coordinator |
HORIZON-JU-GH-EDCTP3-2024-Mpox |
€355,609 |
| 3D Biofabricated high-perfoRmance dna-carbon nanotube dIgital electroniC |
participant |
HORIZON-EIC-2022-PATHFINDEROPEN-01 |
€350,000 |
| Biodiversity Conservation to Mitigate the risks of emerging infectious d |
participant |
HORIZON-CL6-2021-BIODIV-01 |
€251,500 |
| A European Proactive Adaptive Clinical Trials Network within EU-Response |
participant |
HORIZON-HLTH-2024-DISEASE-03-two-stage |
€219,950 |
| Impact of tropical FIRE emissions on rainforest PRODuctivity |
coordinator |
HORIZON-MSCA-2023-PF-01 |
€191,760 |
| Belgian AI Factory Antenna |
participant |
HORIZON-JU-EUROHPC-2025-AIFA-01 |
€182,784 |
| BE READY NOW - EUROPEAN PARTNERSHIP FOR PANDEMIC PREPAREDNESS |
participant |
HORIZON-HLTH-2024-DISEASE-12 |
€131,250 |
| PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccin |
participant |
HORIZON-JU-GH-EDCTP3-2023-01 |
€108,750 |
| Tuberculosis Antimicrobial Stewardship Program (TASP): tackling Bedaquil |
participant |
HORIZON-JU-GH-EDCTP3-2024-01-two-stage |
€71,500 |
| Real-world-data Enabled Assessment for heaLth regulatory decision-Making |
participant |
HORIZON-HLTH-2022-TOOL-11 |
€37,900 |
| Lay Women: International Experts and Theologians avant-la-lettre. Legaci |
associatedPartner |
HORIZON-MSCA-2022-PF-01 |
— |